Preston Klassen

7.8k total citations · 1 hit paper
43 papers, 5.9k citations indexed

About

Preston Klassen is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Preston Klassen has authored 43 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Preston Klassen's work include Dialysis and Renal Disease Management (12 papers), Parathyroid Disorders and Treatments (8 papers) and Blood Pressure and Hypertension Studies (5 papers). Preston Klassen is often cited by papers focused on Dialysis and Renal Disease Management (12 papers), Parathyroid Disorders and Treatments (8 papers) and Blood Pressure and Hypertension Studies (5 papers). Preston Klassen collaborates with scholars based in United States, France and Spain. Preston Klassen's co-authors include Glenn M. Chertow, Edmund G. Lowrie, Geoffrey A. Block, J. Michael Lazarus, Norma J. Ofsthun, Kurt Olson, Lynda A. Szczech, Matthew Guo, Mark D. Danese and John Cunningham and has published in prestigious journals such as JAMA, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Preston Klassen

43 papers receiving 5.6k citations

Hit Papers

Mineral Metabolism, Mortality, and Morbidity in Maintenan... 2004 2026 2011 2018 2004 500 1000 1.5k 2.0k

Peers

Preston Klassen
Dominic S. Raj United States
Robert H. Mak United States
James A. Delmez United States
Ronald J. Hogg United States
Nicole M. Isbel Australia
Preston Klassen
Citations per year, relative to Preston Klassen Preston Klassen (= 1×) peers Björn Meijers

Countries citing papers authored by Preston Klassen

Since Specialization
Citations

This map shows the geographic impact of Preston Klassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preston Klassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preston Klassen more than expected).

Fields of papers citing papers by Preston Klassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preston Klassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preston Klassen. The network helps show where Preston Klassen may publish in the future.

Co-authorship network of co-authors of Preston Klassen

This figure shows the co-authorship network connecting the top 25 collaborators of Preston Klassen. A scholar is included among the top collaborators of Preston Klassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preston Klassen. Preston Klassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandborn, William J., Laurent Peyrin‐Biroulet, Jinkun Zhang, et al.. (2019). Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis. Gastroenterology. 158(3). 550–561. 175 indexed citations
2.
Chiorean, Michael, Séverine Vermeire, Julián Panés, et al.. (2019). 764 Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study. The American Journal of Gastroenterology. 114(1). S445–S446. 2 indexed citations
3.
Turner, Stewart A., et al.. (2018). Safety, tolerability, and pharmacokinetics of APD371, a highly selective CB2 agonist, in healthy adults. Journal of Pain. 19(3). S82–S82. 3 indexed citations
4.
Bahner, Udo, A. P. S. Disney, Stephen Soroka, et al.. (2007). Cinacalcet HCl (Sensipar/ Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clinical Nephrology. 68(7). 10–17. 41 indexed citations
5.
Szczech, Lynda A., Preston Klassen, S. Susan Hedayati, et al.. (2006). Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units. Kidney International. 69(11). 2094–2100. 24 indexed citations
6.
Canaud, Bernard, J.L. Bragg-Gresham, Mark R. Marshall, et al.. (2006). Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney International. 69(11). 2087–2093. 297 indexed citations
7.
Lindberg, Jill S., Bruce F. Culleton, Gordon Tin Chun Wong, et al.. (2005). Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis. Journal of the American Society of Nephrology. 16(3). 800–807. 312 indexed citations
8.
Cunningham, John, Mark D. Danese, Kurt Olson, Preston Klassen, & Glenn M. Chertow. (2005). Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney International. 68(4). 1793–1800. 376 indexed citations
9.
Klassen, Preston, et al.. (2005). Systolic hypertension: An overview. American Heart Journal. 149(5). 769–775. 8 indexed citations
10.
Peacock, Munro, John P. Bilezikian, Preston Klassen, et al.. (2005). Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 90(1). 135–141. 309 indexed citations
11.
Bunout, Daniel, S Hirsch, V Gattás, et al.. (2004). Effects of a nutritional supplement on the immune response and cytokine production in free‐living Chilean elderly. Journal of Parenteral and Enteral Nutrition. 28(5). 348–354. 97 indexed citations
12.
McCullough, Peter A., George L. Bakris, William F. Owen, Preston Klassen, & Robert M. Califf. (2004). Slowing the progression of diabetic nephropathy and its cardiovascular consequences. American Heart Journal. 148(2). 243–251. 26 indexed citations
13.
Pisoni, R., et al.. (2003). Achievement of Proposed NKF-K/DOQI Bone Metabolism and Disease guidelines Results from the dialysis outcomes and practice patterns Study. 269–270. 7 indexed citations
14.
Allen, Andrew S., et al.. (2003). Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. American Journal of Kidney Diseases. 42(6). 1260–1269. 42 indexed citations
15.
Reddan, Donal, et al.. (2003). White blood cells as a novel mortality predictor in haemodialysis patients. Nephrology Dialysis Transplantation. 18(6). 1167–1173. 180 indexed citations
16.
Klassen, Preston. (2002). Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis. JAMA. 287(12). 1548–1548. 309 indexed citations
17.
Szczech, Lynda A., Stephen J. Gange, Charles van der Horst, et al.. (2002). Predictors of proteinuria and renal failure among women with HIV infection. Kidney International. 61(1). 195–202. 197 indexed citations
18.
Coladonato, Joseph A., Diane L. Frankenfield, Donal Reddan, et al.. (2002). Trends in Anemia Management among US Hemodialysis Patients. Journal of the American Society of Nephrology. 13(5). 1288–1295. 57 indexed citations
19.
Reddan, Donal, Lynda A. Szczech, Preston Klassen, & William F. Owen. (2000). Racial Inequity in America's ESRD Program. Seminars in Dialysis. 13(6). 399–403. 49 indexed citations
20.
Klassen, Preston & Laura P. Svetkey. (2000). Diagnosis and Management of Renovascular Hypertension. Cardiology in Review. 8(1). 17–29. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026